KDOQI 血管通路临床实践指南 2019 更新
美国国家肾脏基金会 KDOQI 自 1996 年起为血液透析血管通路提供循证指南,2019 更新版纳入终末期肾病「生命计划」、通路选择、动静脉通路与中心静脉导管新目标及并发症管理等内容,证据质量采用 GRADE 方法独立评价,并遵循 GRADE 证据到决策框架进行解读与应用。
要点
- 新增终末期肾病「生命计划」及相关概念,指导血管通路规划。
- 提供血管通路选择指导,并设定动静脉通路与中心静脉导管的新目标。
- 涵盖特定并发症管理及对部分旧议题的更新方法。
核心结论
- 2019 更新版 KDOQI 血管通路指南为多学科从业者照护慢性肾脏病患者及其血管通路提供循证建议。
研究设计与样本
- 美国国家肾脏基金会 KDOQI 自 1996 年起提供血液透析血管通路循证指南,2019 更新版为综合文件,证据质量采用 GRADE 方法独立评价,解读与应用遵循 GRADE 证据到决策框架。
主要发现
- 新主题包括终末期肾病「生命计划」及相关概念、血管通路选择指导、动静脉通路(瘘管与移植物)和中心静脉导管的新目标、特定并发症管理及对部分旧议题的更新方法。
关键数值与推荐
- 每条指南声明附有理由/背景信息、详细论证、监测与评估指导、实施考虑、专题讨论及未来研究建议。
临床怎么用
- 用于协助多学科从业者照护慢性肾脏病患者及其血管通路,涵盖通路选择、目标设定与并发症管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (KDOQI) has provided evidence-based guidelines for hemodialysis vascular access since 1996. Since the last update in 2006, there has been a great accumulation of new evidence and sophistication in the guidelines process. The 2019 update to the KDOQI Clinical Practice Guideline for Vascular Access is a comprehensive document intended to assist multidisciplinary practitioners care for chronic kidney disease patients and their vascular access. New topics include the end-stage kidney disease "Life-Plan" and related concepts, guidance on vascular access choice, new targets for arteriovenous access (fistulas and grafts) and central venous catheters, management of specific complications, and renewed approaches to some older topics. Appraisal of the quality of the evidence was independently conducted by using a Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach, and interpretation and application followed the GRADE Evidence to Decision frameworks. As applicable, each guideline statement is accompanied by rationale/background information, a detailed justification, monitoring and evaluation guidance, implementation considerations, special discussions, and recommendations for future research.
引用
- Lok CE, Huber TS, Lee T, et al. KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update. Am J Kidney Dis. 2020. PMID: 32778223. doi:10.1053/j.ajkd.2019.12.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。